Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQB-2450 and Chemotherapy Induction Followed by Surgery or Radiotherapy in LS-SCLC
NCT04539977Phase 2Recruiting
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Sep 2020
- Primary completion
- Dec 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of benmelstobart in small cell lung cancer (SCLC), sponsored by Shanghai Pulmonary Hospital. Started Sep 2020; status: recruiting.
02
Drugs
benmelstobart
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT04539977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04539977.